IASSX | VMVAX | IASSX / VMVAX | |
Total Expense Ratio | 1.10 | 0.07 | 1,571% |
Annual Report Gross Expense Ratio | 1.38 | 0.07 | 1,971% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 3.901 | 5.532 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 30.6B | 1% |
Annual Yield % from dividends | 1.42 | 2.26 | 63% |
Returns for 1 year | 2.75 | 9.76 | 28% |
Returns for 3 years | -12.27 | 28.18 | -44% |
Returns for 5 years | 26.48 | 71.82 | 37% |
Returns for 10 years | -6.68 | 93.07 | -7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BKTSX | 29.07 | 0.12 | +0.41% |
iShares Total US Stock Market Idx K | |||
CFIMX | 14.41 | 0.05 | +0.35% |
Clipper | |||
RWICX | 71.86 | 0.03 | +0.04% |
American Funds Capital World Gr&Inc R3 | |||
MCEFX | 14.44 | -0.01 | -0.07% |
BlackRock International Select Eq Inv C | |||
HLEMX | 40.93 | -0.14 | -0.34% |
Harding Loevner Emerging Markets Advisor |